257 related articles for article (PubMed ID: 16258634)
1. Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice.
Fontana L; Souza AS; Del Bel EA; Oliveira RM
Braz J Med Biol Res; 2005 Nov; 38(11):1649-54. PubMed ID: 16258634
[TBL] [Abstract][Full Text] [Related]
2. Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice.
Del Bel EA; Guimarães FS
Psychopharmacology (Berl); 2000 Jan; 147(4):356-61. PubMed ID: 10672628
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.
Lazzarini M; Salum C; Del Bel EA
Psychopharmacology (Berl); 2005 Aug; 181(1):71-9. PubMed ID: 15806417
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery.
Del-Bel EA; Guimarães FS; Joca SR; Echeverry MB; Ferreira FR
J Psychopharmacol; 2010 Mar; 24(3):397-405. PubMed ID: 18838497
[TBL] [Abstract][Full Text] [Related]
5. L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice.
Marras RA; Martins AP; Del Bel EA; Guimarães FS
Neuroreport; 1995 Dec; 7(1):158-60. PubMed ID: 8742441
[TBL] [Abstract][Full Text] [Related]
6. Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice.
Del Bel EA; Souza AS; Guimarães FS; da-Silva CA; Nucci-da-Silva LP
Psychopharmacology (Berl); 2002 Apr; 161(1):32-7. PubMed ID: 11967628
[TBL] [Abstract][Full Text] [Related]
7. Catalepsy induced by nitric oxide synthase inhibitors.
Del Bel EA; da Silva CA; Guimarães FS
Gen Pharmacol; 1998 Feb; 30(2):245-8. PubMed ID: 9580128
[TBL] [Abstract][Full Text] [Related]
8. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
Erkent U; Iskit AB; Onur R; Ilhan M
Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
[TBL] [Abstract][Full Text] [Related]
9. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats.
Del Bel EA; da Silva CA; Guimarães FS; Bermúdez-Echeverry M
Eur J Pharmacol; 2004 Feb; 485(1-3):175-81. PubMed ID: 14757138
[TBL] [Abstract][Full Text] [Related]
10. L-NOARG-induced catalepsy can be influenced by glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus.
Iacopucci AP; Mello RO; Barbosa-Silva R; Melo-Thomas L
Behav Brain Res; 2012 Oct; 234(2):149-54. PubMed ID: 22749845
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase inhibitors cause motor deficits in mice.
Araki T; Mizutani H; Matsubara M; Imai Y; Mizugaki M; Itoyama Y
Eur Neuropsychopharmacol; 2001 Apr; 11(2):125-33. PubMed ID: 11313158
[TBL] [Abstract][Full Text] [Related]
12. Cross-tolerance between nitric oxide synthase inhibition and atypical antipsychotics modify nicotinamide-adenine-dinucleotide phosphate-diaphorase activity in mouse lateral striatum.
Prieto SG; Silva JCS; de Lima MO; Almeida MC; Echeverry MB
Behav Pharmacol; 2019 Feb; 30(1):67-78. PubMed ID: 29664745
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
Gomes FV; Del Bel EA; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of L-NOARG and tiapride: effects on catalepsy in male mice.
Cavas M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):69-73. PubMed ID: 11853122
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in experimental models of psychosis in rats.
Gupta M; Balakrishnan S; Pandhi P
Methods Find Exp Clin Pharmacol; 2001 Nov; 23(9):497-500. PubMed ID: 11876023
[TBL] [Abstract][Full Text] [Related]
16. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y
Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775
[TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.
Kehr J; Yoshitake S; Ijiri S; Koch E; Nöldner M; Yoshitake T
Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S25-34. PubMed ID: 22784425
[TBL] [Abstract][Full Text] [Related]
18. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
Ushijima I; Mizuki Y; Yamada M
Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
[TBL] [Abstract][Full Text] [Related]
19. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: potential implication for the treatment of Parkinsonism?
Krzaścik P; Kostowski W
Pol J Pharmacol; 1997 Aug; 49(4):263-6. PubMed ID: 9437770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
